Oruka Therapeutics, Inc. (ORKA)
Oruka Therapeutics, Inc. (ORKA) Insider Trading
Directors, officers and holders of more than 10% of ORKA report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 266 transactions on file: 0 with code P, 32 with code S and 18 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Klein Lawrence Otto | Chief Executive Officer | S Sale | 15,036 | $95.64 | $1,437,987 |
| Nov 2, 2026 | Klein Lawrence Otto | Chief Executive Officer | M Exercise | 25,000 | Not measured | Not measured |
| Nov 2, 2026 | Klein Lawrence Otto | Chief Executive Officer | S Sale | 756 | $97.45 | $73,676 |
| Nov 2, 2026 | Klein Lawrence Otto | Chief Executive Officer | S Sale | 6,466 | $94.77 | $612,794 |
| Nov 2, 2026 | Klein Lawrence Otto | Chief Executive Officer | S Sale | 2,442 | $96.70 | $236,147 |
| Nov 2, 2026 | Klein Lawrence Otto | Chief Executive Officer | M Exercise | 25,000 | $7.80 | $195,000 |
| Nov 2, 2026 | Klein Lawrence Otto | Chief Executive Officer | S Sale | 300 | $98.40 | $29,521 |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | S Sale | 4,100 | $78.79 | $323,037 |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | S Sale | 3,000 | $79.49 | $238,474 |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | S Sale | 400 | $74.90 | $29,960 |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | S Sale | 1,000 | $77.20 | $77,205 |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | M Exercise | 9,000 | $7.80 | $70,200 |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | S Sale | 500 | $76.12 | $38,059 |
| Oct 20, 2026 | Quinlan Paul T | General Counsel | M Exercise | 9,000 | Not measured | Not measured |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | S Sale | 1,847 | $74.69 | $137,957 |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | S Sale | 2,853 | $73.89 | $210,806 |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | M Exercise | 3,500 | $7.80 | $27,300 |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | M Exercise | 3,500 | $6.84 | $23,940 |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | M Exercise | 3,500 | Not measured | Not measured |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | S Sale | 200 | $77.71 | $15,542 |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | S Sale | 700 | $76.67 | $53,666 |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | S Sale | 1,400 | $75.48 | $105,677 |
| Oct 15, 2026 | Goncalves Joana | Chief Medical Officer | M Exercise | 3,500 | Not measured | Not measured |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | S Sale | 1,958 | $81.86 | $160,272 |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | M Exercise | 8,541 | Not measured | Not measured |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | S Sale | 200 | $82.83 | $16,567 |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | S Sale | 2,100 | $80.76 | $169,596 |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | S Sale | 5,741 | $80.03 | $459,453 |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | M Exercise | 1,458 | $34.39 | $50,141 |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | M Exercise | 8,541 | $12.50 | $106,763 |
| Oct 12, 2026 | Agarwal Arjun | Senior Vice President, Finance | M Exercise | 1,458 | Not measured | Not measured |
| Oct 1, 2026 | Klein Lawrence Otto | Chief Executive Officer | M Exercise | 25,000 | Not measured | Not measured |
| Oct 1, 2026 | Klein Lawrence Otto | Chief Executive Officer | S Sale | 8,554 | $84.03 | $718,755 |
| Oct 1, 2026 | Klein Lawrence Otto | Chief Executive Officer | S Sale | 200 | $84.78 | $16,956 |
| Oct 1, 2026 | Klein Lawrence Otto | Chief Executive Officer | S Sale | 16,246 | $83.40 | $1,354,882 |
| Oct 1, 2026 | Klein Lawrence Otto | Chief Executive Officer | M Exercise | 25,000 | $7.80 | $195,000 |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | S Sale | 2,900 | $92.37 | $267,870 |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | S Sale | 601 | $94.44 | $56,760 |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | S Sale | 3,832 | $93.32 | $357,592 |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | M Exercise | 10,000 | $7.80 | $78,000 |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | M Exercise | 10,000 | Not measured | Not measured |
| Sep 21, 2026 | Quinlan Paul T | General Counsel | S Sale | 2,667 | $95.31 | $254,196 |
| Sep 21, 2026 | Agarwal Arjun | Senior Vice President, Finance | S Sale | 533 | $95.75 | $51,035 |
| Sep 15, 2026 | Goncalves Joana | Chief Medical Officer | M Exercise | 3,500 | $7.80 | $27,300 |
| Sep 15, 2026 | Goncalves Joana | Chief Medical Officer | S Sale | 100 | $94.22 | $9,422 |
| Sep 15, 2026 | Goncalves Joana | Chief Medical Officer | S Sale | 947 | $95.71 | $90,637 |
| Sep 15, 2026 | Goncalves Joana | Chief Medical Officer | S Sale | 2,384 | $91.10 | $217,173 |
| Sep 15, 2026 | Goncalves Joana | Chief Medical Officer | M Exercise | 3,500 | $6.84 | $23,940 |
| Sep 15, 2026 | Goncalves Joana | Chief Medical Officer | S Sale | 1,366 | $92.99 | $127,023 |
| Sep 15, 2026 | Sandler Laura Lee | Chief Operating Officer | S Sale | 906 | $95.71 | $86,713 |
The full Form 4 history is on the ORKA company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.